Reducedp53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic mice
- 1 October 1997
- journal article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 20 (2), 168-174
- https://doi.org/10.1002/(sici)1098-2744(199710)20:2<168::aid-mc3>3.0.co;2-j
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- p53 mutations in matched primary and metastatic human tumorsMolecular Carcinogenesis, 1995
- Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.Genes & Development, 1995
- Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.Proceedings of the National Academy of Sciences, 1994
- The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice.Molecular and Cellular Biology, 1994
- Interactions between SV40 large‐tumor antigen and the growth suppressor proteins pRB and p53The FASEB Journal, 1993
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992
- p53 Mutations in Human CancersScience, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Heart and bone tumors in transgenic mice.Proceedings of the National Academy of Sciences, 1988
- Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenesNature, 1985